1	National	NNP	3	nn
2	Patent	NNP	3	nn
3	Development	NNP	4	nn
4	Corp.	NNP	5	nsubj
5	said	VBD	0	root
6	it	PRP	7	nsubj
7	plans	VBZ	5	ccomp
8	to	TO	9	aux
9	purchase	VB	7	xcomp
10	as	RB	13	quantmod
11	many	JJ	13	quantmod
12	as	IN	13	quantmod
13	200,000	CD	15	num
14	common	JJ	15	amod
15	shares	NNS	9	dobj
16	of	IN	15	prep
17	its	PRP$	22	poss
18	81%-controlled	JJ	22	amod
19	Interferon	NNP	20	nn
20	Sciences	NNP	21	nn
21	Inc.	NNP	22	nn
22	unit	NN	16	pobj
23	in	IN	9	prep
24	periodic	JJ	27	amod
25	,	,	27	punct
26	open-market	JJ	27	amod
27	purchases	NNS	23	pobj
28	.	.	5	punct

1	The	DT	3	det
2	200,000	CD	3	num
3	shares	NNS	7	nsubj
4	are	VBP	7	cop
5	about	RB	6	quantmod
6	23	CD	7	num
7	%	NN	0	root
8	of	IN	7	prep
9	Interferon	NNP	12	poss
10	's	POS	9	possessive
11	common	JJ	12	amod
12	shares	NNS	8	pobj
13	outstanding	JJ	12	amod
14	,	,	7	punct
15	excluding	VBG	7	prep
16	National	NNP	17	nn
17	Patent	NNP	19	poss
18	's	POS	17	possessive
19	stake	NN	15	pobj
20	.	.	7	punct

1	Noting	VBG	18	partmod
2	the	DT	8	det
3	recent	JJ	8	amod
4	Food	NNP	7	nn
5	and	CC	4	cc
6	Drug	NNP	4	conj
7	Administration	NNP	8	nn
8	approval	NN	1	dobj
9	of	IN	8	prep
10	Interferon	NNP	14	poss
11	's	POS	10	possessive
12	genital	JJ	13	amod
13	warts	NNS	14	nn
14	treatment	NN	9	pobj
15	,	,	18	punct
16	National	NNP	17	nn
17	Patent	NNP	18	nsubj
18	said	VBD	0	root
19	it	PRP	20	nsubj
20	believes	VBZ	18	ccomp
21	Interferon	NNP	23	poss
22	's	POS	21	possessive
23	stock	NN	25	nsubj
24	is	VBZ	25	cop
25	undervalued	JJ	20	ccomp
26	.	.	18	punct


